Skip Main Navigation
Page Content
This event has ended

Save This Event

Event Saved

Xconomy Forum: Reinventing Biotech's Business Model

Tuesday, April 3, 2012 from 2:00 PM to 6:00 PM (PDT)

Ticket Information

Ticket Type Sales End Price Fee Quantity
Regular Registration Ended $195.00 $0.00
Startup Special Ended $95.00 $0.00
Student Ended $30.00 $0.00
At the Door Ended $275.00 $0.00

Share Xconomy Forum: Reinventing Biotech's Business Model

Event Details

Xconomy Forum: Reinventing Biotech's Business Model

Biotech companies used to think about how to build enduring companies with soup-to-nuts operations that had everything under one corporate flag, from research to development to manufacturing to marketing. Those models increasingly look like relics. Investors have grown weary of the long timelines, big bucks, and high risk that comes with building such organizations. Stung by losses, a number of VCs, entrepreneurs and investors are turning to small core teams that lean heavily on contract firms to try to make biotech more nimble, less capital intensive, and a more attractive industry for investment. Come join Xconomy for a number of case studies and interactive chats with national leaders who are looking to reinvent the biotech business model.

Confirmed Speakers
Corey Goodman, Partner, venBio
John Maraganore, CEO, Alnylam Pharmaceuticals
Kevin Starr, Partner, Third Rock Ventures
Kathy Glaub, President, Plexxikon
Carl Weissman, CEO, Accelerator
Thong Le, Managing Director, WRF Capital
Bruce Montgomery, CEO, Cardeas Pharma
Heather Franklin, CEO, Blaze Bioscience
Peppi Prasit, Founder, Inception Sciences
David McElligott, Chief Scientific Officer, Groove Biopharma
Steve Tregay, CEO, Forma Therapeutics
Brian Atwood, Managing Director, Versant Ventures
Alex Lash, Biopharma editor, Start-Up, In Vivo   
Ed Saltzman, President, Defined Health
Cliff Stocks, CEO, Theraclone Sciences
John Mendlein, CEO, aTyr Pharma

Full Agenda here.

Registration: 1:00 – 2:00 pm
2:00 – 6:00 pm
Networking Reception: 6:00
– 7:00 pm

Registration information:
Tickets are transferable but not refundable.
To inquire about press registration, e-mail




Christensen O'Connor Johnson Kindness         Cooley LLP

Fenwick & West LLP                         Wells Fargo



Alexandria Real Estate • BDO Christensen O'Connor Johnson Kindness
Cooley LLP
Davis Wright Tremaine • Fenwick & West LLP
Graham & Dunn • IDA Ireland
Institute for Systems Biology
Kauffman Foundation • Kilpatrick Townsend
Puget Sound Blood Center


ARCH Venture Partners • Vulcan Capital • WRF Capital



Have questions about Xconomy Forum: Reinventing Biotech's Business Model? Contact the organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.